• Ten Weeks to Crush the Curve (Eng) - 01/04 Nuevo

​

• Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing (Eng) 31/03 

​

• Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study 31/03 

​

• Medical Education Adaptations: Really Good Stuff for Educational Transition during a Pandemic (Eng) 31/03 Nuevo

​

• Estimates of the severity of coronavirus disease 2019: a model-based analysis (Eng) 30/03 Nuevo

​

• Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months (Eng) 30/04 Nuevo

​

• Covid-19 y Atención Primaria. Las oleadas que vienen: Altas hospitalarias, pacientes críticos sin tratamiento hospitalario y atención demorada que pasa a ser indemorable o urgente (Esp) 30/03 

​

• Estimating the number of infections and the impact of non- pharmaceutical interventions on COVID-19 in 11 European countries (Eng) 30/03 

​

• Angiotensin-Converting Enzyme 2 and Anti-Hypertensives (Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors) in Coronavirus Disease 2019 (COVID-19) 30/03 

​

• Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2 (Esp) 28/03 

​

• COVID19 clinical trials.gob Summary Exponential growth (Eng) 28/03 

​

• Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study (Eng)- 27/03  

​

• Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma (Eng) - 27/03 

​

• Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic (Eng) 27/03 

​

• Video: COVID-19 and Cardiology (Eng) 27/03 

​

• The Global Impact of COVID-19 and Strategies for Mitigation and Suppression (Eng) 27/03 

​

• Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019 (Eng) 26/03

​

• Covid-19: a remote assessment in primary care (Eng) 25/03

​

• The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China (Eng) - 25/03 

​

• Vencer al COVID-19: Vigilancia de los avances globales en CyT (Esp) - 25/03​

​

• Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study (Eng) 24/03 

​

• Coronavirus Disease 2019 in Geriatrics and Long-term Care: The ABCDs of COVID-19 (Eng) 24/03

​

• Papel de la ecografía torácica en el diagnóstico de la neumonía por COVID-19.(Esp) 24/03 

​

• Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection (Eng) 23/03 

​

• Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center (Eng) 23/03 

​

• Fair Allocation of Scarce Medical Resources in the Time of Covid-19 (Eng) 23/03  

​

• La importancia de poseer un activo como la Atención Primaria para hacer frente a la pandemia por coronavirus: cómo desarrollar todo su potencial (Eng) 22/03 

​

• New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws (Eng) 21/03

​

• Video: Cardiac Care in the COVID-19 Pandemic (Eng) 21/03 

​

• COVID-19 infection and rheumatoid arthritis: Faraway, so close! (Eng) 21/03 

​

• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (Eng) 20/03 

​

• COVID-19 and smoking: A systematic review of the evidence (Eng) 20/03 

​

• Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro (Eng) 19/03

​

• Audio Interview: New Research on Possible Treatments for Covid-19 - 19/03

​

• Modelización epidemiológica del COVID-19 - UPV (Esp) 19/03

​

• Prolonged presence of SARS-CoV-2 viral RNA in faecal samples (Eng) 19/03​

​

• Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development (Esp) 18/03

​

• A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 (Eng) 18/03

​

• SARS-CoV-2 Infection in Children (Eng) 18/03

​

• Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (Eng) 17/03 

​

• Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms 17/03

​

• Gestión de las salas de procedimientos invasivos cardiológicos durante el brote de coronavirus COVID-19. (Esp) 16/03

​

• Artículo del Grupo de Trabajo — semFYC en Utilización de Fármacos: Reflexión sobre el uso de ibuprofeno y otros antiinflamatorios en la infección por COVID-19

​

• Recommended psychological crisis intervention response to the 2019 novel coronavirus pneumonia outbreak in China: a model of West China Hospital (Eng) - 15/03

​

• The psychological impact of quarantine and how to reduce it: rapid review of the evidence (Eng)- 14/03

​

• Mental Health and Psychological Intervention Amid COVID-19 Outbreak: Perspectives from South Korea (Eng) 13/03

​

• COVID-19: consider cytokine storm syndromes and immunosuppression (Eng)-13/03 

​

• Risk Factors Associated With Acute Respiratory Distress Syndromeand Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China (Esp) - 13/03

​

•  New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? (Eng) 12/03

​

• Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient - 04/03 ​

​

• Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths (Eng) 4/03

 

• Potential Factors Influencing Repeated SARS Outbreaks in China  (Eng) 3/03

​

• Nitazoxanida, un nuevo fármaco candidato para el tratamiento del coronavirus (Esp) 29/01

​

• Recomendaciones de consenso respecto al SRNI en el paciente adulto con IRA secundaria a infección por SARS-CoV-2- SEPAR (Esp) 

​

• Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine (Eng)

​

• N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel (Eng) - 03/09/19

​

• Constitutive inflammatory cytokine storm: A major threat to human health  (Eng) 08/2019

​

• Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies - 2012

​

• The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus (Eng)  10/2011

​

• Microbial inactivation by microwave radiation in the home environment (Eng) 2007